Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
BIO-key International, Inc is a security & protection services business based in the US. BIO-key International shares (BKYI) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$2.75 - USD$9.8 |
---|---|
50-day moving average | USD$4.2348 |
200-day moving average | USD$3.9906 |
Wall St. target price | USD$2 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-0.556 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$2.3 million |
---|---|
Gross profit TTM | USD$-193,717 |
Return on assets TTM | -21.36% |
Return on equity TTM | -123.37% |
Profit margin | 0% |
Book value | $2.781 |
Market capitalisation | USD$33.3 million |
TTM: trailing 12 months
There are currently 462,173 BIO-key International shares held short by investors – that's known as BIO-key International's "short interest". This figure is 133.1% up from 198,268 last month.
There are a few different ways that this level of interest in shorting BIO-key International shares can be evaluated.
BIO-key International's "short interest ratio" (SIR) is the quantity of BIO-key International shares currently shorted divided by the average quantity of BIO-key International shares traded daily (recently around 810829.8245614). BIO-key International's SIR currently stands at 0.57. In other words for every 100,000 BIO-key International shares traded daily on the market, roughly 570 shares are currently held short.
However BIO-key International's short interest can also be evaluated against the total number of BIO-key International shares, or, against the total number of tradable BIO-key International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BIO-key International's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 BIO-key International shares in existence, roughly 60 shares are currently held short) or 0.0641% of the tradable shares (for every 100,000 tradable BIO-key International shares, roughly 64 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BIO-key International.
Find out more about how you can short BIO-key International stock.
We're not expecting BIO-key International to pay a dividend over the next 12 months.
BIO-key International's shares were split on a 1:8 basis on 20 November 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BIO-key International shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for BIO-key International shares which in turn could have impacted BIO-key International's share price.
Over the last 12 months, BIO-key International's shares have ranged in value from as little as $2.75 up to $9.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BIO-key International's is 1.0694. This would suggest that BIO-key International's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. It offers ID Director, a solution for integration with CA Technologies / Broadcom's Single Sign-on solution, Oracle's Fusion Middleware SSO, IBM Tivoli Access Manager, as well as ISAM and other solutions. The company also provides Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many and one-to-one user identification; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. In addition, it offers WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in unsecure environments, such as the world wide Web or off-site cloud environments. Additionally, the company develops and distributes hardware components; and sells third-party hardware components. BIO-key International, Inc. markets its products through its sales force, as well as through distributors, resellers, integrators, value added resellers, and technology partners. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.